The best Bull and Bear pitches based on recency and number of recommendations.
The small molecules developed by CUR attack disease at the point of origin rather than just mitigation of symptoms. Eventually, once the science fine tunes the delivery system and the molecule targeting system a vast array of diseases will be helped… More
Did you hear that? Me neither. That silence was the sound of Neuralstem not talking about NSI-566, their erstwhile lead program of stem cell therapy for ALS, spinal cord injury, and stroke. The last major development was in August 2015 when the… More
Read the most recent pitches from players about SNCA.DL.
Find the members with the highest scoring picks in SNCA.DL.
See what the Wall Street professionals think, according to their public statements and filings.